Forgot Your Password?
Follow Topic
Bookmark
Copy Link
SSPs implemented amid ongoing supply disruption to Quetiapine tablets.
18 Jul 2024 , 2 Min Article
The Society wants to hear from a wide range of pharmacists and pharmacy team members.
12 Jul 2024 , 2 Min Article
Migraine and antiseizure medication topiramate (Topamax) must no longer be prescribed to women and girls unless they fulfil the requirements of a Pregnancy Prevention Programme
24 Jun 2024 , 1 Min Article
Study looks at the impact of introducing point-of-care testing in primary care
20 Jun 2024 , 1 Min Article
Fifty SSPs were issued between 2022 and 2024 compared with 14 SSPs issued between 2019 and 2021.
03 Jun 2024 , 1 Min Article
Somatropin (NutropinAq) 10mg/2ml solution for injection cartridges have been discontinued.
30 May 2024 , 1 Min Article
Maxwellia's emergency contraceptive pill brand LoviOne clinched two awards at the Prolific North Champions Awards.
13 May 2024 , 1 Min Article
Pharmacy team members report spending over an hour each day tackling meds shortages.
09 May 2024 , 3 Min Article
Four charities said they were “inundated with calls” from patients suffering from epilepsy and Parkinson's disease.
26 Apr 2024 , 1 Min Article
Why are medicines shortages getting so severe? A Nuffield Trust report investigates.
18 Apr 2024 , 3 Min Article
The force, which did not name the pharmacy, said it was alerted after the business’s audit revealed the drugs were missing.
15 Apr 2024 , 1 Min Article
The British Generic Manufacturers Association calls on political parties to back the UK’s struggling off-patent medicines sector.
25 Mar 2024 , 2 Min Article
Ganaxolone (Ztalmy) treats cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder.
14 Mar 2024 , 1 Min Article
Courier company Gophr selected after 'rigorous' information gathering process
05 Mar 2024 , 1 Min Article
Former British Generic Manufacturers' Association chair Peter Ballard said it is "one of the biggest, most damaging causes" of shortages.
27 Feb 2024 , 1 Min Article
Codeine linctus is to be reclassified to a prescription-only medicine due to the risk of abuse, dependency and overdose, the MHRA has announced.
20 Feb 2024 , 1 Min Article